Nuvation Bio (NUVB) news
Recent news
Nuvation Bio shares up 1% after Citigroup initiates coverage with buy rating
Nuvation Bio Inc. (NYSE: NUVB) shares rose 1% following Citigroup's initiation of coverage with a "buy" rating, signaling renewed investor interest in the clinical-stage biotechnology firm. The move comes amid recent institutional activity, including Bank of New York Mellon Corp's acquisition of…
AInvest Wire · Sep 30, 2026Nuvation Bio shares up 2.7% premarket after Citigroup initiates coverage with buy rating
Nuvation Bio Inc. (NYSE: NUVB) shares rose 2.7% in premarket trading following Citigroup's initiation of coverage with a "buy" rating. The move comes as the company continues to attract attention from institutional investors and analysts amid its development of small-molecule therapies for cancer…
AInvest Wire · Sep 30, 2026Nuvation Bio - No changes to ibtrozi safety labeling; no new safety signals identified
AInvest Wire · Sep 17, 2026Nuvation Bio announces FDA approval of SNDA for ibtrozi
AInvest Wire · Sep 17, 2026Nuvation Bio's Phase 3 Sigma study enrollment underway
AInvest Wire · Aug 20, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.